Figure 3.
Timeline for each experiment after neonatal hypoxia-ischemia (HI) of the brain. (A) Location of injected adipose-derived-mesenchymal stem cells (AD-MSCs) in the brain (A(i), postnatal day (PN) 7–17; A(ii), PN8–18). (B) Effect of treatment with AD-MSCs on the absolute number of all medium-spiny neurons (MSNs, B(i)), and the absolute number of progenitors that had differentiated into MSNs (B(ii)), in the caudate-putamen (CPu) at PN21. (C) Effect of treatment with AD-MSCs on cellular proliferation in the dorsolateral subventricular zone (dlSVZ) and the absolute number of microglia in the CPu and dlSVZ (C(i), PN7–17; C(ii), PN8–18). BrdU, bromodeoxyuridine.